These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1338 related items for PubMed ID: 18405785

  • 1. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
    Barrons R, Tassone D.
    Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
    [Abstract] [Full Text] [Related]

  • 2. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S.
    BMC Womens Health; 2008 Jan 15; 8():3. PubMed ID: 18197974
    [Abstract] [Full Text] [Related]

  • 3. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
    Reid G, Dols J, Miller W.
    Curr Opin Clin Nutr Metab Care; 2009 Nov 15; 12(6):583-7. PubMed ID: 19741517
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
    Mastromarino P, Macchia S, Meggiorini L, Trinchieri V, Mosca L, Perluigi M, Midulla C.
    Clin Microbiol Infect; 2009 Jan 15; 15(1):67-74. PubMed ID: 19046169
    [Abstract] [Full Text] [Related]

  • 5. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules.
    Eriksson K, Carlsson B, Forsum U, Larsson PG.
    Acta Derm Venereol; 2005 Jan 15; 85(1):42-6. PubMed ID: 15848990
    [Abstract] [Full Text] [Related]

  • 6. Probiotics in the prevention of recurrences of bacterial vaginosis.
    Parma M, Stella Vanni V, Bertini M, Candiani M.
    Altern Ther Health Med; 2014 Jan 15; 20 Suppl 1():52-7. PubMed ID: 24473986
    [Abstract] [Full Text] [Related]

  • 7. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
    Zárate G, Nader-Macias ME.
    Lett Appl Microbiol; 2006 Aug 15; 43(2):174-80. PubMed ID: 16869901
    [Abstract] [Full Text] [Related]

  • 8. The role of lactobacillus probiotics in the treatment or prevention of urogenital infections--a systematic review.
    Abad CL, Safdar N.
    J Chemother; 2009 Jun 15; 21(3):243-52. PubMed ID: 19567343
    [Abstract] [Full Text] [Related]

  • 9. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy.
    Famularo G, Perluigi M, Coccia R, Mastroiacovo P, De Simone C.
    Med Hypotheses; 2001 Apr 15; 56(4):421-30. PubMed ID: 11339841
    [Abstract] [Full Text] [Related]

  • 10. Probiotics: potential to prevent HIV and sexually transmitted infections in women.
    Bolton M, van der Straten A, Cohen CR.
    Sex Transm Dis; 2008 Mar 15; 35(3):214-25. PubMed ID: 18490864
    [Abstract] [Full Text] [Related]

  • 11. The role of lactobacilli and probiotics in maintaining vaginal health.
    Borges S, Silva J, Teixeira P.
    Arch Gynecol Obstet; 2014 Mar 15; 289(3):479-89. PubMed ID: 24170161
    [Abstract] [Full Text] [Related]

  • 12. Could probiotics be an option for treating and preventing urogenital infections?
    Reid G, Bruce AW.
    Medscape Womens Health; 2001 Oct 15; 6(5):9. PubMed ID: 11698931
    [Abstract] [Full Text] [Related]

  • 13. Probiotic strategies for the treatment and prevention of bacterial vaginosis.
    MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G.
    Expert Opin Pharmacother; 2010 Dec 15; 11(18):2985-95. PubMed ID: 21080853
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of vaginal lactobacilli by a bacteriocin-like inhibitor produced by Enterococcus faecium 62-6: potential significance for bacterial vaginosis.
    Kelly MC, Mequio MJ, Pybus V.
    Infect Dis Obstet Gynecol; 2003 Dec 15; 11(3):147-56. PubMed ID: 15022875
    [Abstract] [Full Text] [Related]

  • 15. [Non-antibiotic prophylaxis for recurrent urinary-tract infections].
    Beerepoot MA, ter Riet G, Verbon A, Nys S, de Reijke TM, Geerlings SE.
    Ned Tijdschr Geneeskd; 2006 Mar 11; 150(10):541-4. PubMed ID: 16566416
    [Abstract] [Full Text] [Related]

  • 16. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H, Larsson PG, Andersen KK, Zuo F, Mikkelsen LS, Brandsborg E, Gray G, Laher F, Otwombe K.
    BMC Infect Dis; 2019 Sep 18; 19(1):824. PubMed ID: 31533663
    [Abstract] [Full Text] [Related]

  • 17. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
    Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR.
    Arzneimittelforschung; 1996 Jan 18; 46(1):68-73. PubMed ID: 8821521
    [Abstract] [Full Text] [Related]

  • 18. Effect of lactobacilli administration in the vaginal tract of mice: evaluation of side effects and local immune response by local administration of selected strains.
    Vintiñi E, Ocaña V, Elena Nader-Macías M.
    Methods Mol Biol; 2004 Jan 18; 268():401-10. PubMed ID: 15156050
    [Abstract] [Full Text] [Related]

  • 19. Disruption of urogenital biofilms by lactobacilli.
    McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, Fu J, Abbas A, Dang T, Miller W, Reid G.
    Colloids Surf B Biointerfaces; 2011 Aug 01; 86(1):58-64. PubMed ID: 21497071
    [Abstract] [Full Text] [Related]

  • 20. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
    Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S.
    BJOG; 2009 Sep 01; 116(10):1315-24. PubMed ID: 19538417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.